Biography

As a Gates scholar, I completed my PhD in Pathology with a project in cancer genomics where I used CRISPR technology (then very new) to elucidate the function in cancer progression of a gene of interest. After brief postdoctoral positions at the University of Cambridge, I worked as a research scientist in Genetic Modification Services at the Francis Crick Institute, where I was a molecular biologist and also established their bioinformatics pipeline for validating long reads (using Nanopore sequencing) to identify any CRISPR unintended edits. That lab provided bespoke gene edited mice for the various research labs at the Crick. I am currently a senior scientist in Gene Editing at the Wellcome Sanger Institute, which provides a similar CRISPR-edited bespoke gene modification service, but does so in induced pluripotent stem cells rather than mice.